Use of Template to Increase Referral of Hematology/Oncology Patients to Palliative Care/Hospice Service When Appropriate

Article Type
Changed
Mon, 09/09/2019 - 14:43

Background: Patients with late stage metastatic cancer unresponsive to front line therapies have a poor prognosis and yet are often admitted to the ICU or other acute care settings without having had referral to palliative care/hospice service for goals-of-care discussion. In order to increase awareness of the need to consider palliative care/hospice services early in the course of patients with poor-prognosis cancer, we developed a template in the progress notes of CPRS. The template required response to two questions: is this patient appropriate for referral to palliative care and/or hospice service; if so, why and if not, why not? Completion of the template was required to continue the note.

Methods: We initiated the template in April 2018 and we evaluated numbers of patients referred to palliative care/hospice services in the 12-month period prior to, and 12-month period after initiating the template. Prior to initiating the template, there were 99 consults to palliative care/hospice and 2375 patients not referred.

Results: For the 12- month period after introduction of the template, there were 138 patients referred for palliative care/hospice and consults to palliative care/ hospice and 2314 patients not referred. The odds risk for referring after the template compared to prior to the template was 1.4 (95% CI: 1.098-1.864, P=0.004). Thus, patients were 1.43 times more likely to be referred to palliative care/hospice services after initiation of the template. Further research to know the reasons for referral and the precise diagnosis of patients who were referred is ongoing.

Conclusion: This study suggests that addition of a template to the CPRS chart can raise awareness of the need for palliative care/hospice consultations when appropriate.

Author and Disclosure Information
Correspondence: Paulette Mehta ([email protected])
Publications
Topics
Sections
Author and Disclosure Information
Correspondence: Paulette Mehta ([email protected])
Author and Disclosure Information
Correspondence: Paulette Mehta ([email protected])

Background: Patients with late stage metastatic cancer unresponsive to front line therapies have a poor prognosis and yet are often admitted to the ICU or other acute care settings without having had referral to palliative care/hospice service for goals-of-care discussion. In order to increase awareness of the need to consider palliative care/hospice services early in the course of patients with poor-prognosis cancer, we developed a template in the progress notes of CPRS. The template required response to two questions: is this patient appropriate for referral to palliative care and/or hospice service; if so, why and if not, why not? Completion of the template was required to continue the note.

Methods: We initiated the template in April 2018 and we evaluated numbers of patients referred to palliative care/hospice services in the 12-month period prior to, and 12-month period after initiating the template. Prior to initiating the template, there were 99 consults to palliative care/hospice and 2375 patients not referred.

Results: For the 12- month period after introduction of the template, there were 138 patients referred for palliative care/hospice and consults to palliative care/ hospice and 2314 patients not referred. The odds risk for referring after the template compared to prior to the template was 1.4 (95% CI: 1.098-1.864, P=0.004). Thus, patients were 1.43 times more likely to be referred to palliative care/hospice services after initiation of the template. Further research to know the reasons for referral and the precise diagnosis of patients who were referred is ongoing.

Conclusion: This study suggests that addition of a template to the CPRS chart can raise awareness of the need for palliative care/hospice consultations when appropriate.

Background: Patients with late stage metastatic cancer unresponsive to front line therapies have a poor prognosis and yet are often admitted to the ICU or other acute care settings without having had referral to palliative care/hospice service for goals-of-care discussion. In order to increase awareness of the need to consider palliative care/hospice services early in the course of patients with poor-prognosis cancer, we developed a template in the progress notes of CPRS. The template required response to two questions: is this patient appropriate for referral to palliative care and/or hospice service; if so, why and if not, why not? Completion of the template was required to continue the note.

Methods: We initiated the template in April 2018 and we evaluated numbers of patients referred to palliative care/hospice services in the 12-month period prior to, and 12-month period after initiating the template. Prior to initiating the template, there were 99 consults to palliative care/hospice and 2375 patients not referred.

Results: For the 12- month period after introduction of the template, there were 138 patients referred for palliative care/hospice and consults to palliative care/ hospice and 2314 patients not referred. The odds risk for referring after the template compared to prior to the template was 1.4 (95% CI: 1.098-1.864, P=0.004). Thus, patients were 1.43 times more likely to be referred to palliative care/hospice services after initiation of the template. Further research to know the reasons for referral and the precise diagnosis of patients who were referred is ongoing.

Conclusion: This study suggests that addition of a template to the CPRS chart can raise awareness of the need for palliative care/hospice consultations when appropriate.

Publications
Publications
Topics
Article Type
Sections
Citation Override
Abstract Presented at the 2019 Association of VA Hematology/Oncology Annual Meeting
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 09/09/2019 - 14:45
Un-Gate On Date
Mon, 09/09/2019 - 14:45
Use ProPublica
CFC Schedule Remove Status
Mon, 09/09/2019 - 14:45
Hide sidebar & use full width
render the right sidebar.

When Substance Abuse Interferes with Cancer Treatment

Article Type
Changed
Thu, 12/15/2022 - 15:13
Display Headline
When Substance Abuse Interferes with Cancer Treatment

Article PDF
Author and Disclosure Information

Madhu Midathada, MD, Jason Mehta, BA, Rangaswamy Govindarajan, MD, A. Mazin Safar, MD, D. Micah Hester, PhD, M. Jameel Kyasa, MD, and Paulette Mehta, MD

At the time of this writing, Dr. Midathada was a hematology/oncology fellow at the University of Arkansas for Medical Sciences (UAMS) and a staff physician at the Central Arkansas Veterans Healthcare System (CAVHS), both in Little Rock. She is now in private practice in Lincoln, NE. Mr. Mehta is a third year law student at Harvard Law School, Cambridge, MA. Drs. Govindarajan and Safar are both associate professors in the division of hematology/oncology, Dr. Hester is an assistant professor of biomedical ethics in the division of medical humanities, Dr. Kyasa is an assistant professor in the division of hematology/oncology, and Dr. Mehta is a professor of hematology/oncology in the departments of internal medicine and pediatrics, all at the UAMS. In addition, Drs. Safar, Kyasa, and Mehta are staff physicians in hematology/oncology at the CAVHS.

Issue
Federal Practitioner - 23(9)
Publications
Topics
Page Number
39
Legacy Keywords
substance abuse, cancer, ethics, alcoholism, drug abusesubstance abuse, cancer, ethics, alcoholism, drug abuse
Sections
Author and Disclosure Information

Madhu Midathada, MD, Jason Mehta, BA, Rangaswamy Govindarajan, MD, A. Mazin Safar, MD, D. Micah Hester, PhD, M. Jameel Kyasa, MD, and Paulette Mehta, MD

At the time of this writing, Dr. Midathada was a hematology/oncology fellow at the University of Arkansas for Medical Sciences (UAMS) and a staff physician at the Central Arkansas Veterans Healthcare System (CAVHS), both in Little Rock. She is now in private practice in Lincoln, NE. Mr. Mehta is a third year law student at Harvard Law School, Cambridge, MA. Drs. Govindarajan and Safar are both associate professors in the division of hematology/oncology, Dr. Hester is an assistant professor of biomedical ethics in the division of medical humanities, Dr. Kyasa is an assistant professor in the division of hematology/oncology, and Dr. Mehta is a professor of hematology/oncology in the departments of internal medicine and pediatrics, all at the UAMS. In addition, Drs. Safar, Kyasa, and Mehta are staff physicians in hematology/oncology at the CAVHS.

Author and Disclosure Information

Madhu Midathada, MD, Jason Mehta, BA, Rangaswamy Govindarajan, MD, A. Mazin Safar, MD, D. Micah Hester, PhD, M. Jameel Kyasa, MD, and Paulette Mehta, MD

At the time of this writing, Dr. Midathada was a hematology/oncology fellow at the University of Arkansas for Medical Sciences (UAMS) and a staff physician at the Central Arkansas Veterans Healthcare System (CAVHS), both in Little Rock. She is now in private practice in Lincoln, NE. Mr. Mehta is a third year law student at Harvard Law School, Cambridge, MA. Drs. Govindarajan and Safar are both associate professors in the division of hematology/oncology, Dr. Hester is an assistant professor of biomedical ethics in the division of medical humanities, Dr. Kyasa is an assistant professor in the division of hematology/oncology, and Dr. Mehta is a professor of hematology/oncology in the departments of internal medicine and pediatrics, all at the UAMS. In addition, Drs. Safar, Kyasa, and Mehta are staff physicians in hematology/oncology at the CAVHS.

Article PDF
Article PDF

Issue
Federal Practitioner - 23(9)
Issue
Federal Practitioner - 23(9)
Page Number
39
Page Number
39
Publications
Publications
Topics
Article Type
Display Headline
When Substance Abuse Interferes with Cancer Treatment
Display Headline
When Substance Abuse Interferes with Cancer Treatment
Legacy Keywords
substance abuse, cancer, ethics, alcoholism, drug abusesubstance abuse, cancer, ethics, alcoholism, drug abuse
Legacy Keywords
substance abuse, cancer, ethics, alcoholism, drug abusesubstance abuse, cancer, ethics, alcoholism, drug abuse
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media